Clarity Pharmaceuticals (ASX:CU6) has seen the U.S. FDA fast-track its prostate cancer imaging compound for use in PET scans on patients with recurring prostate cancer. The stock jumped 4% in the ...

Researchers have developed a breakthrough method to detect inflammation in the body using positron emission tomography (PET) imaging. This innovative probe targets CD45, a marker abundantly expressed ...

Chief minister Sukhvinder Singh Sukhu says HIMCARE scheme is operational in all government hospitals of the state. “The BJP ...

Advanced imaging with PSMA-PET has found unexpected metastatic disease in many prostate cancer patients, potentially altering the course of treatment and challenging prior clinical trial methodologies ...

Artificial intelligence has the potential to improve the analysis of medical image data. For example, algorithms based on deep learning can determine the location and size of tumors. This is the ...